Videos
On today’s show, Preston Pysh talks with Lyn Alden and Jeff Booth about the status of the Bitcoin bull market. They talk about the Elon Musk FUD, and numerous other hot topics.

IN THIS EPISODE, YOU’LL LEARN:
– What Elon Musk’s impact will be on Bitcoin
– Bitcoin energy concerns
– Bitcoin centralization concerns
– Bitcoin Payment times
– Stanley Druckenmiller’s comments on the dollar losing global reserve status
– How the corporate boards view the Bitcoin volatility
– How Bitcoin helps fix an inflationary monetary system
– Ethereum’s bull run versus Bitcoin’s bull run

Subscribe to We Study Billionaires podcast show: https://link.chtbl.com/WSB
To access our show notes, courses or forums, go to theinvestorspodcast.com.
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ADDITIONAL INVESTING RESOURCES:
Ask the Investors: https://www.youtube.com/playlist?list=PL_xlkwLDH1F8msJn1pD3z95KuFLQWPuf-

Asset Allocation Course: https://www.youtube.com/playlist?list=PL_xlkwLDH1F9coxc1aExB8xbw9daFDF6P

Real Estate Investing: https://www.youtube.com/playlist?list=PL_xlkwLDH1F_p00VYv3psJ8rhDAGOvR5W

Millennial Investing: https://www.youtube.com/playlist?list=PL_xlkwLDH1F-NVcnR47rMkT0ByTWQBvBf
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
Download Stig & Preston’s 1-page checklist for finding great stock picks: https://www.theinvestorspodcast.com/form-youtube-checklist/

Have a question? Get your voice heard on the show: https://www.theinvestorspodcast.com/your-questions/
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
DISCLAIMER: This show is for entertainment purposes only. Before making any decisions consult a professional. This show is copyrighted by The Investor’s Podcast Network. Written permission must be granted before syndication or rebroadcasting.

Articles You May Like

Greenlight’s David Einhorn says the markets are broken and getting worse
BlackRock expands its tokenized money market fund to Polygon and other blockchains
Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally
Top Wall Street analysts like these dividend-paying stocks
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value